Read More at Fight Aging! Fight Aging! publishes news and commentary relevant to the goal of ending all age-related disease, to be achieved by bringing the mechanisms of aging under the control of modern medicine. This weekly newsletter is sent to thousands of interested subscribers. To subscribe or unsubscribe from the newsletter, please visit: https://www.fightaging.org/newsletter/ Longevity Industry Consulting Services Reason, the founder of Fight Aging! and Repair Biotechnologies, offers strategic consulting services to investors, entrepreneurs, and others interested in the longevity industry and its complexities. To find out more: https://www.fightaging.org/services/ Contents The Burden of Somatic Mutation with Age Back to Debating Limits to Human Life Span Again More on the Debate Over the Classification of Aging as a Disease Stem Cell Derived Extracellular Vesicles Reduce Epigenetic Age in Mice Aubrey de Grey Establishes the Longevity Escape Velocity Foundation A Subpopulation…
Fight Aging! Newsletter, October 24th 2022
Read More at Fight Aging! Fight Aging! publishes news and commentary relevant to the goal of ending all age-related disease, to be achieved by bringing the mechanisms of aging under the control of modern medicine. This weekly newsletter is sent to thousands of interested subscribers. To subscribe or unsubscribe from the newsletter, please visit: https://www.fightaging.org/newsletter/ Longevity Industry Consulting Services Reason, the founder of Fight Aging! and Repair Biotechnologies, offers strategic consulting services to investors, entrepreneurs, and others interested in the longevity industry and its complexities. To find out more: https://www.fightaging.org/services/ Contents An Update on Senolytics Company Cleara Biotech Testing Narrow Epigenetic Clocks in Centenarians Notes from the Rejuvenation Startup Summit, Held in Berlin in October 2022 A View of the Road Ahead to Viable Xenotransplantation There is Such a Thing as Too Much of a Focus on Low-Hanging Fruit in…
Notes from the Rejuvenation Startup Summit, Held in Berlin in October 2022
Read More at Fight Aging! A fair number of longevity industry and related companies presented this past weekend in Berlin, at the Rejuvenation Startup Summit hosted by the Forever Healthy Foundation. Unlike the past Undoing Aging events, this is much more focused on the industry rather than on scientific programs, but there was nonetheless a great deal of science on display. I took a few notes in between other activities, for posterity. As Michael Greve noted in his introduction to the participants, these are the early years of what will become the largest industry on the planet. Everyone ages, and everyone is a customer for the rejuvenation therapies and related technologies that lie just around the corner. Eric Verdin of the Buck Institute gave the opening keynote, discussing recent work on biomarkers of aging, and specifically the most promising line…
Fight Aging! Newsletter, October 17th 2022
Read More at Fight Aging! Fight Aging! publishes news and commentary relevant to the goal of ending all age-related disease, to be achieved by bringing the mechanisms of aging under the control of modern medicine. This weekly newsletter is sent to thousands of interested subscribers. To subscribe or unsubscribe from the newsletter, please visit: https://www.fightaging.org/newsletter/ Longevity Industry Consulting Services Reason, the founder of Fight Aging! and Repair Biotechnologies, offers strategic consulting services to investors, entrepreneurs, and others interested in the longevity industry and its complexities. To find out more: https://www.fightaging.org/services/ Contents RAS/MAPK Pathway Inhibition as an Example of the Way in Which Cancer Research Informs Aging Research An Interesting Delivery Method for GDF11 Mitochondrial Stress Provokes Inflammation via Fragments of Mitochondrial DNA A Few Years of Difference in Life Expectancy Between Poorest and Wealthiest in Spain In Health and Mortality,…
Fight Aging! Newsletter, October 10th 2022
Read More at Fight Aging! Fight Aging! publishes news and commentary relevant to the goal of ending all age-related disease, to be achieved by bringing the mechanisms of aging under the control of modern medicine. This weekly newsletter is sent to thousands of interested subscribers. To subscribe or unsubscribe from the newsletter, please visit: https://www.fightaging.org/newsletter/ Longevity Industry Consulting Services Reason, the founder of Fight Aging! and Repair Biotechnologies, offers strategic consulting services to investors, entrepreneurs, and others interested in the longevity industry and its complexities. To find out more: https://www.fightaging.org/services/ Contents Commentary on Old Age in the International Classification of Diseases The Problem with Biomarkers of Aging Still No Success Worthy of the Name in Anti-Amyloid Immunotherapies to Treat Alzheimer’s Disease Interventions Testing Program Results for Rapamycin and Arcabose in Combination Correlation Between a Worse Gut Microbiome and Aging of…
Fight Aging! Newsletter, October 3rd 2022
Read More at Fight Aging! Fight Aging! publishes news and commentary relevant to the goal of ending all age-related disease, to be achieved by bringing the mechanisms of aging under the control of modern medicine. This weekly newsletter is sent to thousands of interested subscribers. To subscribe or unsubscribe from the newsletter, please visit: https://www.fightaging.org/newsletter/ Longevity Industry Consulting Services Reason, the founder of Fight Aging! and Repair Biotechnologies, offers strategic consulting services to investors, entrepreneurs, and others interested in the longevity industry and its complexities. To find out more: https://www.fightaging.org/services/ Contents A Small Lifespan Study of Combined Interventions Amyloid-β in the View of Alzheimer’s as a Condition Driven by Persistent Infection Prevention and Effective Treatment of Atherosclerosis Should Be a High Priority A Mechanism by Which Herpesvirus May Accelerate Amyloid-β Aggregation Leading to Alzheimer’s Disease Rapamycin in Early Life Delays…